BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9333111)

  • 1. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Pharmacol Toxicol; 1999 Mar; 84(3):143-6. PubMed ID: 10193676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
    Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine.
    Isohanni MH; Neuvonen PJ; Palkama VJ; Olkkola KT
    Eur J Clin Pharmacol; 1998 Sep; 54(7):561-5. PubMed ID: 9832299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.
    Kantola T; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Aug; 64(2):177-82. PubMed ID: 9728898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
    Otsuji Y; Okuyama N; Aoshima T; Fukasawa T; Kato K; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K
    Ther Drug Monit; 2002 Jun; 24(3):375-8. PubMed ID: 12021628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
    Niemi M; Tornio A; Pasanen MK; Fredrikson H; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam.
    Osanai T; Ohkubo T; Yasui N; Kondo T; Kaneko S
    Br J Clin Pharmacol; 2004 Nov; 58(5):476-81. PubMed ID: 15521894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ; Jalava KM
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
    Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone.
    Kivistö KT; Lamberg TS; Neuvonen PJ
    Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.
    Raaska K; Niemi M; Neuvonen M; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2002 Oct; 72(4):362-9. PubMed ID: 12386638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.
    Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
    Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.